Clinical Trial Update: Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA) [Phase 4]

View source ↗

Summary

Phase 4 long-term follow-up study of risdiplam in Spinal Muscular Atrophy; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Risdiplam (Evrysdi) (risdiplam)

Snippet

Sponsor: Genentech, Inc. | Conditions: Spinal Muscular Atrophy | Phase 4 | Status: ACTIVE_NOT_RECRUITING